Duke Health Provider
Michael J. Kelley, MD
Medical Oncologist
Duke Health Provider
Call for an Appointment
Where I See Patients
Durham VA Health Care System - Durham, NC
Board Certified
American Board of Internal Med, Medical Oncology
American Board of Internal Med, Internal Medicine
Call for an Appointment
My Locations
Durham VA Health Care System
Open
508 Fulton St
Durham,
NC
27705
About Me
Current Appointments and Affiliations
- Professor of Medicine, Medicine, Medical Oncology 2014
- Member of the Duke Cancer Institute, Duke Cancer Institute 1998
Languages I Speak
English
Call for an Appointment
Training and Education
Board Certification
American Board of Internal Med, Medical Oncology
American Board of Internal Med, Internal Medicine
Fellowship
Medical Oncology, National Cancer Institute (Maryland), 1993
Residency
Internal Medicine, Duke University Medical Center, 1985-1988
Education
MD, University of Michigan Medical School, 1985
Clinical Focus and Research
Publications and Grants
Grants25
Academic Articles210
Conference Papers96
- Targeting the tumor microenvironment to enhance immunotherapy for SCLC awarded by Department of Defense 2025 - 2027
- Postdoctoral Training in Genomic Medicine Research awarded by National Institutes of Health 2017 - 2023
- Williams, Christina D., Karen M. Stechuchak, Leah L. Zullig, Dawn Provenzale, and Michael J. Kelley. “Influence of comorbidity on racial differences in receipt of surgery among US veterans with early-stage non-small-cell lung cancer.” J Clin Oncol 31, no. 4 (February 1, 2013): 475–81. https://doi.org/10.1200/JCO.2012.44.1170.
- Kelley, Michael J., Jeffrey A. Bogart, Lydia D. Hodgson, Rafat H. Ansari, James N. Atkins, Herbert Pang, Mark R. Green, and Everett E. Vokes. “Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206.” J Thorac Oncol 8, no. 1 (January 2013): 102–8. https://doi.org/10.1097/JTO.0b013e31827628e1.
- Zullig, Leah L., George L. Jackson, Raye Anne Dorn, Dawn T. Provenzale, Rebecca McNeil, Catherine M. Thomas, and Michael J. Kelley. “Cancer incidence among patients of the U.S. Veterans Affairs Health Care System.” Mil Med 177, no. 6 (June 2012): 693–701. https://doi.org/10.7205/milmed-d-11-00434.
- Lichtenstein, Morgan R. L., Laura A. Levit, Caroline Schenkel, Kelsey Kirkwood, Lola A. Fashoyin-Aje, Suanna S. Bruinooge, Michael J. Kelley, et al. “Researcher Experience and Comfort With Telemedicine and Remote Patient Monitoring in Cancer Treatment Trials.” In The Oncologist, 29:356–63, 2024. https://doi.org/10.1093/oncolo/oyad237.
- Zullig, Leah L., Amy Jeffreys, Whitney Raska, Gina McWhirter, and Michael J. Kelley. “Quality of telehealth-provided cancer care in VA.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 42, 2024.
- Patil, Vikas, Richard Mcshinsky, Ahmad Sami Halwani, Deborah Morreall, Chunyang Li, Kelli M. Rasmussen, Christina Yong, et al. “Implementing a natural language processing pipeline to expedite clinical chart review to assess germline genetic testing in veterans with breast cancer.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 42, 2024.
Insurance Accepted
Please call to see if your insurance is accepted.
External Relationships
This faculty member (or a member of their immediate family) has reported outside activities with the companies or institutions listed below. This information has been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts of interest.
- Bristol Myers Squibb
- Mirati
- Plexus Communications
- Prime Education
- Regeneron Pharmaceuticals